Epidemiologic evaluation of inhaled nitric oxide use among neonates with gestational age less than 35 weeks.

Allison M PelusoHasan F OthmanSreenivas KarnatiIbrahim SammourHany Z Aly

Published in: Pediatric pulmonology (2021)

Usage of iNO was higher after the release of the consensus statement. The increased use of iNO among preterm neonates may be targeted at specific high-risk populations such as SGA and CHD neonates. There was lower mortality in Epoch 2; however, the cost was doubled.

Keyphrases

gestational age
low birth weight
preterm birth
birth weight
nitric oxide
preterm infants
cardiovascular events
cystic fibrosis
risk factors
hydrogen peroxide
type diabetes
cancer therapy
drug delivery
body mass index
physical activity